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The traditional classification of dementia distinguished vascular cognitive impairment from Alzheimer disease, 
describing different pathophysiological pathways. More 
recently, it has been hypothesized that even Alzheimer disease 
can be viewed as a predominantly vascular disorder.1,2 Indeed, 
it shares with cardiovascular disease several risk factors, as 
well as some mechanisms of disease, including the NO path-
way.3,4 Furthermore, structural alterations that are an expres-
sion of vascular aging, such as a large artery stiffness5–7 and 
carotid atherosclerosis,8,9 have been associated with a steeper 
cognitive decline.
Based on these findings, it is conceivable that interventions 
aimed at restoring endothelial function and reducing large artery 
stiffness might be beneficial in prevention of dementia. In the past 
few years, there has been a growing interest toward multidomain 
interventions for prevention of dementia, including lifestyle mea-
sures, cognitive training, and vascular risk monitoring, especially 
in individuals at increased risk,10 but to date, few and conflicting 
data exist about the effect of multidomain interventions on vas-
cular biomarkers and their possible role in dementia prevention. 
Thus, the diagnostic and therapeutic implications of the acknowl-
edgment of vascular roots of dementia remain elusive.2
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controls, patients had at study entry a reduced flow-mediated dilation (2.97±2.14% versus 3.73±2.06%; P=0.03) and 
hyperemic stimulus (shear rate area under the curve, 19.1±15.7 versus 25.7±15.1×10−3; P=0.009); only the latter remained 
significant after adjustment for confounders (P=0.03). Training improved Alzheimer disease assessment scale cognitive 
(training, 14.0±4.8 to 13.1±5.5; nontraining, 12.1±3.9 to 13.2±4.8; P for interaction visit×training=0.02), flow-mediated 
dilation (2.82±2.19% to 3.40±1.81%, 3.05±2.08% to 2.24±1.59%; P=0.006; P=0.023 after adjustment for diameter 
and shear rate area under the curve), and circulating hematopoietic CD34+ cells and prevented the decline in carotid 
distensibility (18.4±5.3 to 20.0±6.6, 23.9±11.0 to 19.5±7.1 Pa−1; P=0.005). The only clinical predictor of improvement 
of cognitive function after training was established hypertension. There was no correlation between changes in measures 
of cognitive and vascular function. In conclusion, a multidomain training program slows cognitive decline, especially 
in hypertensive individuals. This effect is accompanied by improved systemic endothelial function, mobilization of 
progenitor CD34+ cells, and preserved carotid distensibility.
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Within this framework, the Italian National Research 
Council launched a prospective, randomized, parallel-group, 
open-label clinical trial called Train the Brain, enrolling elder 
patients with mild cognitive impairment (MCI), to investigate 
the efficacy of a protocol of physical exercise and cognitive 
stimulation on cognitive and vascular function. MCI is a sub-
clinical condition favoring the clinical onset of dementia11 and 
is possibly associated with impaired vascular function.12
Whereas the results regarding the primary outcome (cog-
nitive function) were published elsewhere,13 the analysis pre-
sented in this article is aimed at investigating the relationship 
between vascular function and structure and cognitive func-
tion (the Train the Brain–Mind the Vessel study). Specifically, 
the 2 main objectives were
• to identify, in a cross-sectional analysis, vascular fea-
tures associated with MCI in comparison with controls 
with normal cognitive function;
• to investigate, in an interventional prospective study, the 
effects of a program of environmental enrichment, in-
cluding cognitive, social, and exercise training, on vas-
cular function and structure and the possible relationship 
between cognitive and vascular outcomes.
Methods
Study Protocol
An expanded Methods section, including a detailed description of 
the multimodality training program and measurements, is available 
in Methods in the online-only Data Supplement and Figure S1 in the 
online-only Data Supplement. The data that support the findings of 
this study are available from the corresponding author on reasonable 
request.
Results
Cross-Sectional Study: Comparison Between MCI 
and Non-MCI
One hundred fifty-eight patients in total were recruited for the 
Train the Brain study; 113 subjects were defined as having 
MCI at the neurological examination; 45 were not. Among 
them, 131 participants accepted to undergo the cardiovascular 
evaluation at baseline, 91 MCI and 40 non-MCI (Figure 1).
Baseline clinical characteristics are shown in Table S1. 
The 2 groups showed no significant differences in the main 
clinical characteristics, with the exception of age. As expected, 
ADAS-cog was lower in patients with non-MCI than in MCI 
(8.9±3.3 versus 13.6±4.6; P=0.004).
Flow-mediated dilation (FMD) assessment was successful 
in 36 non-MCI (90%) and in 85 MCI (93%). Main reasons for 
failure were arm movements during the examination and low-
quality images. MCI showed a reduced FMD and hyperemic 
stimulus (evaluated as peak hyperemic shear rate [SR] and SR 
area under the curve [AUC] until peak time) in comparison with 
non-MCI, whereas brachial artery diameter and response to glyc-
eryl trinitrite were similar (Table 1). FMD was no longer signifi-
cantly different between MCI and non-MCI when SR AUC was 
added as a covariate (P=0.18). When results were adjusted for 
age, body mass index, and total cholesterol, only the difference 
in SR AUC remained statistically significant (P=0.03), whereas 
the difference in FMD and peak hyperemic SR was attenuated 
(P=0.19 and 0.14, respectively). No differences were found in 
carotid–femoral pulse wave velocity (PWV), aortic pressure or 
its augmentation, and carotid geometry or elasticity (Table 1).
The number of circulating progenitor cells was measured 
in 36 non-MCI (90%) and 68 MCI (75%). MCI and non-MCI 
showed similar number of CD34+ (1.3±0.8 versus 1.7±1.4 n/μL; 
P=0.14) and endothelial progenitor cells (EPC; 0.05±0.08 ver-
sus 0.04±0.05 n/μL; P=0.78).
Effect of Training on Clinical and Cognitive 
Characteristics
Clinical characteristics of MCI individuals accepting to per-
form vascular evaluation and completing the 7-month follow-
up were reported in Table S2. There were no differences at 
baseline in clinical characteristics, except for a higher preva-
lence of statin use in MCI nontraining individuals, with simi-
lar cholesterol values (Table S2). Furthermore, no differences 
in main clinical characteristics were found in MCI individu-
als accepting to enter the vascular substudy as compared with 
those enrolled in the main study.13
ADAS-Cog (Alzheimer Disease Assessment Scale 
Cognitive), which was significantly different at T0 (P<0.05), 
increased after the 7-month period, in the nontraining and 
decreased in the training group, with statistical significance 
for both the time/treatment interaction and the intragroup 
comparisons, thus showing a positive effect of the intervention 
(14.0±4.5 to 13.1±5.5 for MCI training; 12.1±3.9 to 13.2±4.8 
for MCI nontraining; time×treatment P=0.02).
Office blood pressure (BP) was similarly and sig-
nificantly reduced in MCI training (141.3±15.8/72.9±7.9 
to 133.8±14.6/68.6±8.7 mm Hg) and MCI nontraining 
(141.3±18.8/72.7±10.4 to 136.1±15.3/68.2±9.0 mm Hg). 
However, an increase in number of antihypertensive drugs or 
in dosage ≥50% occurred in a significantly greater proportion 
of MCI nontraining (n=6, 18.8%) versus MCI training (n=1, 
1.9%; P=0.006). No significant changes in body mass index, 
heart rate, lipid, and glucose profile were found (Table S3).
Effect of Training on Vascular Variables
When vascular characteristics at T0 were compared between 
the 2 treatment arms, MCI nontraining showed a higher hyper-
emic stimulus for FMD, both expressed as peak hyperemic SR 
and SR AUC, than MCI training (Table 2). The 2 treatment 
arms had different SR AUC at baseline, which, however, did 
not change after 7 months in any group. Brachial artery diam-
eter showed also a significantly different behavior over time in 
the 2 groups, indicating a more favorable remodeling in MCI 
training (Table 2; Figure 2). FMD in the brachial artery had a 
diverging trend over time in the 2 treatment arms. In particular, 
FMD showed an increase in the training arm and a reduction in 
the control arm (time×treatment P=0.006). In the mixed-model 
analysis, a significant interaction visit×training (P=0.017) was 
confirmed even when considering brachial artery diameter and 
SR AUC as covariates; furthermore, FMD at T7 was higher in 
the training than in the nontraining group (P=0.016, Bonferroni 
post hoc comparison test). Response to glyceryl trinitrite was 
similar in the 2 treatment arms and unchanged from T0 to T7.
Comparing vascular characteristics at T0, MCI nontrain-
ing showed a higher carotid distension, leading to a signifi-




 http://ahajournals.org by on Septem
ber 17, 2019
1220  Hypertension  June 2018
MCI training (Table 2). A diverging trend between groups 
was observed for carotid distensibility. Indeed, distensibil-
ity, which was higher at T0 in MCI nontraining than in MCI 
training group, was reduced over time in the MCI nontraining 
and preserved in MCI training, with a significant interaction 
time–treatment (Figure 2). The other carotid parameters had a 
similar behavior: in particular, elastic modulus was increased 
from T0 to T7 in the control but not in the treatment arm 
(Table 2). In parallel with the brachial artery, exercise and 
cognitive training tended to prevent negative carotid remod-
eling, whereas no significant effect was observed on intima–
media thickness (Figure 2). There was no difference in the 
behavior over time of carotid–femoral PWV, central BP, and 
its augmentation, which were unchanged in both groups.
After 7 months of training, a significant increase in CD34+ 
cells (1.17±0.7 to 1.53±0.6 per μL; P=0.004), but not in EPC 
(0.06±0.08 to 0.05±0.08 per μL; P=0.26), was only observed 
in MCI training group, suggesting a favorable effect of the 
training on the hematopoietic cell mobilization. No significant 
changes in either CD34+ cells (1.8±0.9 versus 1.4±0.3 per 
μL; P=0.16) or EPC (0.05±0.07 versus 0.039±0.06 per μL; 
P=0.77) were found in MCI nontraining.
Predictors of Cognitive Outcome in MCI Training
In the MCI training group, established hypertension at 
study entry was the only clinical variable associated with a 
significantly greater improvement of ADAS-cog after train-
ing (ΔADAS-cog, −2.3±2.7 in hypertensive versus 0.3±5.0 
in normotensive patients; P=0.02). In particular, no differ-
ences between sexes were found (ΔADAS-cog, −1.2±4.6 in 
women versus −0.7±3.8 in men; P=0.52), whereas no sig-
nificant correlation between age at T0 and ΔADAS-cog was 
found (r=0.006; P=0.94). Indeed, a significant reduction in 
ADAS-cog was observed only in hypertensive patients, with 
a significant time×group interaction (Figure 3). Furthermore, 
absolute ADAS-cog change was significantly and inversely 
correlated to aortic systolic BP at T0 (r=−0.32; P=0.02; 
Figure S2), PP at T0 (r=−0.35; P=0.01), and number of anti-
hypertensive drugs at T0 (r=−0.30; P=0.03). Interestingly, this 
result occurred regardless of the degree of mean BP reduction, 
which was similar in hypertensive and normotensive individu-
als (Figure 3). Among vascular characteristics at T0, hyper-
emic SR AUC (r=0.37; P=0.009), carotid stiffness (r=−0.32; 
P=0.02), and Young elastic modulus (r=−0.37; P=0.009) were 
significantly associated with ΔADAS-cog in the univariate 
analysis. However, all these associations lost significance 
when adjusted for hypertensive status (P=0.29, 0.14, and 
0.18, respectively). Finally, ΔADAS-cog was not associated 
with absolute changes in either mean BP (r=0.01; P=0.93) or 
any of the vascular parameters measured, neither in the whole 
MCI training group, nor in the hypertensive/normotensive 
individuals (data not shown).
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Discussion
The Train the Brain study, was a prospective, randomized, paral-
lel-group, open-label clinical trial conducted by Italian National 
Research Council (CNR) aimed at investigating the safety and 
efficacy of a multimodality training program on vascular and cog-
nitive outcomes in individuals at risk for developing dementia.
The main finding of the Train the Brain–Mind the Vessel 
study is that in MCI, a 7-month multidomain training program 
is able to induce a significant improvement in vascular end 
points, such as systemic endothelial function and carotid dis-
tensibility, and to slow cognitive decline, though modestly. The 
proposed training opposes the physiological effect of aging 
on arterial vessels, namely endothelial dysfunction, negative 
arterial remodeling, and loss of elasticity. An original finding 
is that the multidomain training program is more effective in 
hypertensive rather than in normotensive MCI individuals, 
indicating that an intervention aimed at combating the vascular 
roots of dementia is more beneficial in this subset of popula-
tion, in whom this mechanism is probably more relevant.
Effects of Training on Endothelial Function
A combined 7-month cognitive and exercise training is able 
to increase FMD and CD34+ cell mobilization in patients with 
MCI. Based on these results is it possible to speculate that endo-
thelial dysfunction might be a crucial mechanism of disease and 
a reasonable target for prevention of dementia, though the study 
design does not allow to demonstrate that the training-induced 
improvement in cognitive function and in vascular function 
is causally related. CD34+ cells are a more immature popula-
tion of bone marrow-derived progenitors, including EPCs and 
nonendothelial progenitor cells, which potentially involved in 
maintenance of the vascular homeostasis.14 Mobilization of 
progenitor pluripotent cells from the bone marrow, activated 
by the multidomain training, might contribute to the restora-
tion of vascular integrity and functionality.14 NO plays a critical 
role in the mobilization of progenitor cells15 and in the FMD 
response.16 Experimental studies demonstrated that reduced 
brain NO availability causes increased β-amyloid deposition 
by several mechanisms, including hypoperfusion and altered 
β-amyloid clearance,3,4 suggesting that loss of cerebral endothe-
lial NO plays a role in the initiation and progression of cognitive 
decline.4 Conversely, conflicting data exist in humans: 2 small 
case–control studies indicate that either FMD12 or the reactivity 
of skin microcirculation17 is altered in initial cognitive impair-
ment, whereas in the general population of the Framingham 
Offspring Study, FMD is not associated with brain volume or 
cognitive function tests.18 However, it is important to acknowl-
edge that impaired FMD in MCI is at least, in part, mediated by 
concomitant classical cardiovascular risk factors, as indicated 
by the attenuation of the difference between MCI and healthy 
controls when adjusted for confounders, as well by reduced 
hyperemic stimulus, which is per se an index of microvascular 
dysfunction. This is in line with our results on progenitor cells, 
showing no significant differences in CD34+ and EPC levels 
between patients with MCI and healthy individuals, as reported 
also in a previous study.19 On the other hand, epidemiological 
evidence suggests that several traditional CV risk factors, all 
associated with reduced endothelial NO availability,20 predis-
pose to dementia2,21 and that their treatment might prevent it10. 
Further studies are needed to demonstrate whether endothelial 
dysfunction is the missing link between exposure to cardiovas-
cular risk factors and dementia.
Though the presence of endothelial dysfunction in patients 
with MCI cannot be clearly demonstrated in our study, the rel-
evant effect of multimodality training on 2 different measures 
of systemic endothelial function suggests that progression 
to dementia might be slowed through endothelium-related 
mechanisms.
Effects of Training on Large Artery Distensibility
It is well established that increased carotid–femoral PWV—a 
key marker of vascular aging—is associated with cogni-
tive decline.3,5,6,21 In contrast, neutral results were found in the 
Rotterdam Study for carotid stiffness.7 In the Train the Brain–
Mind the Vessel study, a comprehensive vascular characteriza-
tion was performed at 2 distinct time points, demonstrating the 
effectiveness of a rather short-term and low-intensity interven-
tion on cognitive and vascular outcomes in elderly individuals at 
risk for dementia. Reduced carotid distensibility might directly 
Table 1. Vascular Variables at T0 (Non-MCI vs MCI)
Variables Non-MCI MCI P Value
 n=39 n=83  
Mean carotid diameter, mm 7.86±0.83 8.00±0.87 0.45
Diastolic carotid diameter, mm 7.60±0.82 7.76±0.84 0.34
Intima–media thickness, µm 754±131 773±158 0.92
Distension, mm 0.515±0.125 0.543±0.154 0.42
Compliance, mm2 KPa−1 0.87±0.25 0.93±0.34 0.45
Distensibility, Pa−1 19.5±6.3 20.0±7.9 0.73
Stiffness, m/s 7.49±1.09 7.52±1.19 0.96
Elastic modulus, KPa 505.5±181.6 521.5±232.7 0.94
Carotid PP, mm Hg 56.2±12.3 59.5±16.5 0.48
n=38 n=89
Augmentation pressure, mm Hg 18.1±6.0 17.9±7.6 0.85
Augmentation index, % 34.3±9.7 30.7±8.7 0.053
Aortic systolic BP, mm Hg 128.0±14.0 127.0±15.8 0.74
Aortic PP, mm Hg 53.0±11.2 55.3±14.0 0.38
Mean BP, mm Hg 96.8±10.1 94.1±10.2 0.18
HR, bpm 63.9±8.2 65.3±11.0 0.48
Pulse wave velocity, m/s 10.47±1.94 10.86±2.00 0.34
n=35 n=86
Baseline brachial artery diameter, 
mm
4.14±0.79 4.30±0.86 0.25
FMD, % 3.69±2.07 3.00±2.14 0.03
Baseline shear rate, s−1 321±123 305±170 0.20
Peak hyperemic shear rate, s−1 1329±754 1066±640 0.06
SR AUC, s−2×103 25.7±15.0 19.2±15.7 0.009
Dilation to nitroglycerin, % 7.65±4.52 6.37±3.50 0.11
AUC indicates area under the curve; BP, blood pressure; FMD, flow-mediated 
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cause increased transmission of pressure and flow pulsatility to 
the microcirculation, as well as plaque rupture and emboliza-
tion, thus causing brain hypoperfusion, which is a trigger for 
β-amyloid deposition.2,22 Given the known BP dependence of 
vascular stiffness parameters, it is of relevance that the beneficial 
effect on carotid elasticity in the treatment group was achieved 
in the presence of a BP reduction similar to the control group 
and with a substantially stable glucose and lipid profile in both 
groups. These results are also supported by the significant effect 
of training not only on distensibility but also on Young elastic 
modulus—an index of the intrinsic stiffness of wall material. In 
our view, lack of effect of training on carotid–femoral PWV is 
not in contrast with its well-known association with cognitive 
decline in large population studies but is rather because of its 
unresponsiveness to physical exercise; indeed, a recent review of 
the current literature pointed out that PWV is hardly modifiable 
by exercise in middle-aged and older adults with hypertension.23
Hypertension as a Predictor of Cognitive Outcome 
in MCI
Hypertension is considered a major risk factor for cognitive 
decline and dementia.24 Experimental studies suggest that 
hypertension induced by transverse aortic coartation is able to 
induce brain β-amyloid deposition and cognitive impairment 
acting on vascular mechanisms.25 In humans, pooled analysis 
of several randomized controlled trials testing BP-lowering 
drugs in the elderly showed that BP reduction is associated 
with a reduced incidence of dementia, even after a follow-up 
of few years.26,27 It is also conceivable the reduced incidence 
of dementia during the last 3 decades is attributable, at least 
in part, to a better treatment of vascular risk factors, includ-
ing hypertension.28 In our study, the only predictor of cognitive 
response to the combined physical and cognitive training is a 
previous diagnosis of hypertension. Of note, the improvement 
in cognitive function after training is not related to BP reduc-
tion achieved in this relatively short-term intervention trial. It is 
conceivable that vascular alterations play a role in development 
of cognitive impairment only in individuals with established 
cardiovascular risk factors, such as hypertension. Within the 
spectrum ranging from Alzheimer disease to vascular cognitive 
impairment, pathogenesis of dementia in normotensive indi-
viduals might be more tightly related to extravascular factors, 
making negligible the positive impact of physical training.
Limitations
A major limitation of the study is that in the MCI nontraining 
group, the acceptance rate to the vascular substudy was only 
62%, and the dropout rate during the intervention, though low 
in both groups, was higher compared with that in MCI train-
ing, leading to an underrepresentation of the control arm, with 
Table 2. Behavior of Vascular Variables at T0 and T7 in Patients With MCI Randomized to Active 
Treatment (MCI Training) or Usual Care (MCI Nontraining)
Variables MCI Nontraining MCI Training P Value
 n=28 n=51  
Dilation to nitroglycerin, % 6.80±3.14 7.01±4.28 6.24±3.70 6.84±3.72 0.72
Baseline shear rate, s−1 291±113 249±111 317±199 308±246 0.48
Peak hyperemic shear rate, s−1 857±423 722±303 1205±728* 1022±664 0.78
n=27 n=52  
Diastolic carotid diameter, mm 7.66±0.97 7.73±0.88 7.83±0.75 7.61±0.83 0.07
Wall cross-sectional area, mm2 16.9±5.2 17.3±5.3 17.1±3.5 16.2±3.5 0.21
Distension, mm 0.619±0.180 0.517±0.140† 0.512±0.130* 0.516±0.160 0.01
Compliance, mm2 KPa−1 1.07±0.46 0.88±0.26 0.87±0.25* 0.89±0.31 0.03
Stiffness, m/s 7.02±1.42 7.57±1.37 7.72±1.03* 7.46±1.07 0.02
Elastic modulus, KPa 444.5±182.3 512.8±215.8† 557.4±253.7* 491.6±148.1 0.03
Carotid PP, mm Hg 60.6±18.6 56.5±14.4 57.7±13.7 54.6±11.9 0.77
n=28 n=51  
Augmentation pressure, mm Hg 16.2±6.4 18.7±10.3 17.5±6.9 17.6±8.3 0.19
Augmentation index, % 29.1±8.7 30.3±9.1 31.3±8.4 30.7±10.8 0.39
Aortic systolic BP, mm Hg 125.8±13.0 130.3±20.7 126.2±14.8 126.9±16.2 0.38
Aortic PP, mm Hg 54.3±13.6 58.0±18.3 54.4±11.8 54.6±12.9 0.27
Mean BP, mm Hg 93.2±9.7 95.6±13.4 94.1±9.9 94.7±11.9 0.57
HR, bpm 67.5±9.8 65.3±11.1 65.0±11.6 66.3±11.1 0.09
Pulse wave velocity, m/s 10.22±1.43 10.47±1.48 11.09±2.23* 11.22±2.36* 0.66
P value is for interaction time–treatment (repeated measures ANOVA). BP indicates blood pressure; HR, heart rate; MCI, mild 
cognitive impairment; and PP, pulse pressure.
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possible introduction of a selection bias. Furthermore, though 
the 2 treatment arms were matched for the main clinical charac-
teristics, the MCI training group had a higher ADAS-cog and a 
lower carotid distensibility at baseline: this fact might have influ-
enced the results of the study because of regression to the mean.
The implementation of a multidomain training, though 
coherent with the multifactorial pathophysiology of dementia 
and supported by current literature,10,29,30 did not allow identi-
fying which training component is the most effective on vas-
cular variables and cognitive function. It is conceivable that 
most of the beneficial effects on the vasculature are related 
to exercise training,31 which is able to improve NO availabil-
ity32 and has a sympathoinhibitory effect.33 On the contrary, 
though interventions aimed at restoring vascular health might 
contribute to reduce the global burden of dementia,30 we can-
not completely exclude that improvement of cognitive func-
tion in our study was induced mainly by the cognitive training 
only. Furthermore, it is important to acknowledge that another 
important component of the study intervention is to counter-
act social isolation—an established risk factor and therapeutic 
target for dementia34—is now considered an emerging cardio-
vascular risk factor, increasing per se cardiovascular morbid-
ity and mortality.35 The design of the study does not allow 
demonstrating that the training-induced improvements in 
cognitive function and vascular function are causally related. 
In the present study, endothelial dysfunction was measured in 
the brachial artery, whereas NO-related mechanisms favoring 
dementia were demonstrated in the cerebral circulation and in 
experimental settings. These results are hardly translatable to 
humans because currently available noninvasive techniques36,37 
may not measure accurately the cerebral endothelial function. 
Finally, because the T7 visit occurred 7 to 21 days after the 
end of the intervention, the observed improvements in vascu-
lar function may have been underestimated.
Perspectives
In conclusion, a nonpharmacological, combined physical, 
social, and cognitive training slows, and partly reverses, the 
decline in cognitive function, endothelial function, and carotid 
elasticity in a population of elderly individuals with MCI. The 
results of the present study suggest a role of vascular factors 
in the individuals. Accordingly, the proposed intervention to 
prevent cognitive decline might find its clinical application 
in the hypertensive subset of population at risk of dementia. 
However, this hypothesis should be taken with caution because 
there seems to be no correlation between changes in vascular 
and cognitive function at the individual level and need to be 
Figure 3. Effect of multidomain training of ADAS-cog and mean 
blood pressure (BP) in hypertensive and normotensive groups 
in the mild cognitive impairment (MCI) training treatment arm. 
Data are expressed as mean±SEM. P values (time×group) 
were obtained by repeated measures ANOVA. Yellow squares: 
hypertensive MCI-training patients; green squares: normotensive 
MCI-training patients. *P<0.05, hypertensive vs normotensive 
MCI training patients in post hoc analysis; #P<0.05 T0 vs T7 in 
post hoc analysis.
Figure 2. Behavior of main vascular parameters in mild cognitive impairment (MCI) individuals at T0 and T7. Data are expressed as 
mean±SEM. P values (time×treatment) were obtained by repeated measures ANOVA. AUC indicates area under the curve; BA, brachial 
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supported by larger prospective studies aimed at investigating 
whether interventions aimed at improving vessel structure and 
function will translate in slowing cognitive decline.
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What Is New?
•	 In individuals with mild cognitive impairment, who are at risk for demen-
tia, a 7-month cognitive and physical training program had a positive 
effect on cognitive function.
•	The training program increases endothelial function, circulating hemato-
poietic CD34+ cells and reduced carotid stiffness.
What Is Relevant?
•	Cognitive function was improved by the combined training program only 
in hypertensive individuals.
Summary
A 7-month multidomain training slows, though modestly, cogni-
tive decline, especially in hypertensive individuals. This effect is 
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